ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1306

MRI Erosions in Undifferentiated Arthritis. Different Associations with the Collagen IIA N-Terminal Propeptide (PIIANP) and Galectin-3 in Pre-RA and Other Arthritides

Saida Farah Issa1, Anne Duer2, Mikkel Østergaard3, Hanne Lindegaard1, Kim Hørslev-Petersen4, Merete Lund Hetland5, Jakob M. Møller6, Anne Friesgaard Christensen7 and Peter Junker1, 1Department of Rheumatology, Odense University Hospital, Odense, Denmark, 2Department of Rheumatology, Copenhagen University Hospital at Hvidovre, Hvidovre, Denmark, 3Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 4Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark, 5DANBIO, Center for Rheumatology and Spine Diseases, Glostrup Univ Hospital, Glostrup, Denmark, 6Department of Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark, 7Department of Rheumatology, Vejle Hospital, Vejle, Denmark

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Collagen, Galectin and rheumatoid arthritis (RA), MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Galectin-3 has been
implicated as a mediator of inflammation and erosive progression in animal
arthritis and rheumatoid arthritis(RA). The type IIA procollagen peptide(PIIANP)
is an emerging seromarker for cartilage collagen II synthesis and we have previously reported subnormal
levels in patients with newly diagnosed, untreated RA.

The
aims were to study A. Baseline galectin-3 and PIIANP in patients with
undifferentiated arthritis and to compare the levels in pre-RA and other
arthritides; B. The relationship between galectin-3 and PIIANP with disease
phenotype and MRI findings.

Methods: Patients categorized with early,
undifferentiated arthritis(n=116) were followed up for at least 12 months after
which they were reclassified according to appropriate criteria(TUDAR)(1). Baseline variables included
demographics, biochemical and clinical disease activity measures. Baseline MRI was obtained of
the dominant wrist, MCP, PIP and MTP joints. One hundred and twenty individuals
served as controls. Galectin-3
and PIIANP were measured by ELISA(R&D, Millipore/Linco Research).

Results: Galectin-3 was significantly increased in patients with undifferentiated
arthritis, 4.42 ng/ml (95%
CI 4.08;4.75
) vs. controls, 3.96 ng/ml (95% CI 3.70;4.22, p =
0.03), particularly in the
pre-RA subset,  4.99 ng/ml (95% CI 4.30;5.67, p =
0.002). Conversely, galectin-3 in patients with other arthritides than future RA did not
differ from healthy controls (fig 1a). PIIANP was also
increased in the entire group, 1800 ng/ml  (IQR 1440;2250) vs.
healthy controls, 888 ng/ml (IQR 742;1029, p < 0.0001). However, when stratifying
according to pre-RA and other kinds of arthritis, PIIANP was equally
increased in these two subsets, 1752 ng/ml  (IQR 1483.5;2067, p <
0.0001) and 1801 ng/ml  (IQR 1436;2260, p < 0.0001). Galectin-3
and PIIANP did not associate with clinical disease activity measures. However, PIIANP
correlated
negatively with total MRI erosion score in patients with pre-RA, rho=-0.83  p = 0.009.    

                            

 


Conclusion : These
findings indicate that synovitis of any origin elicits a regenerative
chondrogenic response. However,
the
inverse correlation between PIIANP and baseline MRI erosion score
in pre-RA indicates that cartilage collagen II metabolism is skewed
towards a net catabolic state in this arthritis subset. This altered cartilage
metabolic profile may relate to the increased galectin-3 expression in
patients with pre-RA.

1        
Duer-Jensen A et al. Arthritis Rheum. 2011;63:2192-202


Disclosure: S. F. Issa, None; A. Duer, None; M. Østergaard, None; H. Lindegaard, None; K. Hørslev-Petersen, None; M. Lund Hetland, None; J. M. Møller, None; A. F. Christensen, None; P. Junker, None.

To cite this abstract in AMA style:

Issa SF, Duer A, Østergaard M, Lindegaard H, Hørslev-Petersen K, Lund Hetland M, Møller JM, Christensen AF, Junker P. MRI Erosions in Undifferentiated Arthritis. Different Associations with the Collagen IIA N-Terminal Propeptide (PIIANP) and Galectin-3 in Pre-RA and Other Arthritides [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mri-erosions-in-undifferentiated-arthritis-different-associations-with-the-collagen-iia-n-terminal-propeptide-piianp-and-galectin-3-in-pre-ra-and-other-arthritides/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-erosions-in-undifferentiated-arthritis-different-associations-with-the-collagen-iia-n-terminal-propeptide-piianp-and-galectin-3-in-pre-ra-and-other-arthritides/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology